StockNews.AI
INDV
StockNews.AI
3 days

Indivior to Participate in Upcoming Investor Events

1. Indivior will participate in Morgan Stanley's Healthcare Conference on September 8. 2. CEO Joe Ciaffoni will discuss company strategy in a fireside chat. 3. The company also attends H.C. Wainwright's Global Investment Conference on September 9. 4. Indivior is focused on treating opioid use disorder (OUD) globally. 5. Their product pipeline aims to enhance OUD treatment options.

8m saved
Insight
Article

FAQ

Why Bullish?

Participation in investor events often boosts investor confidence and engagement. Historical examples show stock prices often rise post such events if positive discussions occur.

How important is it?

Investor conferences are pivotal for understanding company direction and may impact stock valuation. Positive engagements could lead to increased investor interest.

Why Short Term?

The conferences are approaching quickly, potentially impacting stock price in the immediate future.

Related Companies

PFEJNJAMGN

RICHMOND, Va., Aug. 20, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ:INDV) today announced that it will participate in the following investor events:

  • Morgan Stanley 23rd Annual Global Healthcare Conference – New York City, NY



    Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meetings on Monday, September 8th. Joe Ciaffoni will also participate in a fireside discussion on Monday, September 8th at 9:15 a.m. U.S. ET. Interested investors should contact their Morgan Stanley representative to schedule a meeting. The fireside discussion will be publicly available and can be viewed using the following weblink: Morgan Stanley Webcast Link
  • H.C. Wainwright 27th Annual Global Investment Conference – New York City, NY



    Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meetings on Tuesday, September 9th. Interested investors should contact their H.C. Wainwright representative to schedule a meeting.

About Indivior

Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients around the world will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Headquartered in the United States in Richmond, VA, Indivior employs over 1,000 individuals globally and its portfolio of products is available in over 30 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior. 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/indivior-to-participate-in-upcoming-investor-events-302534769.html

SOURCE Indivior

Related News